Lithium Orotate 5 mg

Lithium Orotate 5 mg

KAL4.7 (14,429 ratings)
Format:Capsule Quantity: 120 VegCap(s) · 120 servings
Goals

Product analysis

92 out of 100

Lithium Orotate 5 mg is inexpensive, but its link to improved mood remains uncertain at this supplement amount.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality100

Lithium orotate is a clearly identified form with a favourable form comparison. That choice does not establish a mood benefit at the supplement’s amount.

Ingredient Transparency100

The lithium amount and orotate form are clearly stated. That makes direct comparisons with other lithium supplements straightforward.

Value For Money80

The serving price is favourable in its cost comparison. A low cost does not establish that the supplement will improve mood.

Customer Satisfaction92

Customers are strongly positive about the supplement. A very large review base makes the satisfaction pattern well established, without proving a mood benefit.

Product Focus82

The single ingredient formula has a narrow mood-related purpose. Findings for monitored prescription lithium cannot establish the same benefit from this supplement serving.

Format
Capsule
Container
120 VegCap(s)
Per serving
$0.11
Customer rating
4.7 · 14,429 ratings
Report analysis

Goals

Mood Support
Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic

Lithium orotate supplies 5 mg lithium per serving. Evidence for monitored prescription lithium cannot establish a mood benefit at this supplement exposure, despite the saved amount receiving full consideration.

How this product is rated for Mood Support

Ingredient fit100

Lithium account for the main saved ingredient contribution. Amounts and preparation details constrain the comparison.
Goal fit
Lithium is the main ingredients counted toward mood support.
Dose adequacy
The declared serving amounts receive substantial consideration; this compares amounts with supplied reference ranges, without proving a mood effect.

Pathways56

The strongest saved connection is to neuroinflammation and neuroplasticity, based on the counted ingredients; this does not itself demonstrate emotional improvement.
Depth
The strongest saved connection is to neuroinflammation and neuroplasticity, based on the counted ingredients; this does not itself demonstrate emotional improvement.
Breadth
One mood-related area reaches the saved coverage threshold, leaving the other areas less represented.

Evidence82

Lithium provides the strongest saved evidence contribution here; its population and outcome limitations still apply.
Evidence strength
Lithium provides the strongest saved evidence contribution here; its population and outcome limitations still apply.
Studied preparation
The counted ingredients meet the saved preparation criteria; this does not make all labelled forms interchangeable with every clinical trial.

Formulation logic100

The counted ingredients have no unmet partner requirement or matched ingredient conflict. Their amount criteria describe the saved comparison rather than proven effectiveness.
Partner coverage
The counted ingredients require no missing partner under the supplied findings; this does not imply an added benefit from combining them.
Conflicts
No listed ingredient conflict was matched in the supplied findings; this does not establish medication compatibility.
Effective doses
The counted ingredients meet the saved minimum amount criterion.
Study evidence
Lithium Supportive 197 studies

Ingredients

IngredientAmount per servingScore
Lithium (Lithium Orotate)
5 mg 96
Adults 18–50 Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value
A serving provides 5 mg of lithium from lithium orotate. The whole-product serving costs about $0.12.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

Lithium Orotate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.
Lithium Compound Optimization
Lithium Orotate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.

Dose, Safety & Label Transparency100

The stated 5 mg per serving is the amount of lithium itself, making it possible to compare with other amounts given on the same basis.
Elemental Disclosure Precision
The amount of lithium itself is stated as 5 mg per serving, rather than only the weight of its source compound.
Dosage Appropriateness
A serving contains 5 mg of lithium.

Value80

The whole-product serving costs about $0.12 and supplies 5 mg of lithium.
Cost Per Serving Efficiency
The whole-product serving costs about $0.12 and supplies 5 mg of lithium.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M · Bipolar disorders · 2019
    Guideline / consensusMood Support forLithium
  2. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS; GERI-BD Study Group · The American journal of psychiatry · 2017
    Randomized trial224 participantsMood Support forLithium
  3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Lamictal 606 Study Group · Archives of general psychiatry · 2003
    Randomized trial175 participantsMood Support forLithium
  4. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N · Molecular psychiatry · 2022
    Meta-analysis9,821 participants41 studies pooledMood Support forLithium
  5. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R · The Journal of clinical psychiatry · 2004
    Meta-analysis638 participants2 studies pooledMood Support forLithium